Latest News


April 2021

iX Biopharma is pleased to announce it has entered into a cooperation deal with China Resources Pharmaceutical Commercial Group...

Read On


February 2021

iX Biopharma Ltd. has reported its first half results for the financial year as of 31 December 2020...

Read On

Our Sublingual Technology

Sublingual wafer administration offers the convenience of use over oral delivery, circumventing the drug breakdown in liver or gastrointestinal tract. The technology also provides rapid absorption, achieving maximum desirable therapeutic effect in a non-invasive manner.

Read On

Contact us

iX Biopharma Ltd

1 Kim Seng Promenade
#14-01 Great World City East Tower
Singapore 237994
T: +65 6235 2270
F: +65 6235 2170